Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Amanda M. Healan"'
Autor:
Robert A. Salata, Jeffrey L. Blumer, Mary Ann O'Riordan, Wesley A. Gray, Howard M. Proskin, Amanda M. Healan, J. McLeod Griffiss
Publikováno v:
Clinical Pharmacology in Drug Development. 8:436-442
There is an urgent need to identify safe and effective combination treatments for multidrug-resistant (MDR) Mycobacterium tuberculosis infection (TB). Bedaquiline, a new diarylquinoline, is approved for the treatment of MDR pulmonary TB in combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfec9f131c75969517468cc8656ffe02
https://doi.org/10.1002/cpdd.639
https://doi.org/10.1002/cpdd.639
Autor:
Howard M. Proskin, Jeffrey L. Blumer, Robert A. Salata, Amanda M. Healan, J. McLeod Griffiss, Wesley A. Gray, Mary Ann O'Riordan
Publikováno v:
Antimicrobial agents and chemotherapy, vol 62, iss 1
Bedaquiline is a diarylquinoline that specifically inhibits mycobacterial ATP synthase. Bedaquiline has been used to effectively treat tuberculosis (TB) caused by drug-susceptible and drug-resistant Mycobacterium tuberculosis . Rifamycins are a corne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb337ce05d355b53d0a02fb410ec1b8
https://escholarship.org/uc/item/6z80h96f
https://escholarship.org/uc/item/6z80h96f
Autor:
Edward J. Fuchs, Robert A. Salata, J. M. Griffiss, Jeffrey L. Blumer, Wesley A. Gray, Amanda M. Healan
Publikováno v:
Antimicrobial agents and chemotherapy, vol 56, iss 12
Colistimethate sodium, increasingly used to treat multidrug-resistant Gram-negative infections, spontaneously hydrolyzes to form colistin A (polymyxin E1) and B (polymyxin E2/B) when mixed with water. High levels of these active breakdown products at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2105c8cf2d42ddbe2d358c212fb5dd2e
https://europepmc.org/articles/PMC3497204/
https://europepmc.org/articles/PMC3497204/